Clinical and hematological responses to hydroxyurea in sicilian patients with Hb S/β-thalassemia

Hemoglobin

Volumn 25, Issue 1, 2001, Pages 9-17

  Rigano, P ^a   Rodgers, G P ^a   Renda, D ^a   Renda, M C ^a   Aquino, A ^a   Maggio, A ^a  

^a VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN S; HYDROXYUREA;

ADULT; ARTICLE; BETA THALASSEMIA; DISEASE COURSE; DRUG EFFICACY; DYSPEPSIA; FEMALE; HUMAN; ITALY; MALE; MEAN CORPUSCULAR VOLUME; PHENOTYPE; RASH; SICKLE CELL ANEMIA; SICKLE CELL CRISIS;

ADULT; ANTISICKLING AGENTS; BLOOD CELL COUNT; BONE MARROW DISEASES; FEMALE; HETEROZYGOTE; HOSPITALIZATION; HUMANS; HYDROXYUREA; MALE; MIDDLE AGED; PHENOTYPE; SICILY; SICKLE CELL TRAIT; THALASSEMIA; TREATMENT OUTCOME;

EID: 0035096303     PISSN: 03630269     EISSN: None     Source Type: Journal    
DOI: 10.1081/HEM-100103065     Document Type: Article

References (22)

1. Mortality in sickle cell disease. Life expectancy and risk factors for early death
2. Multicenter study of hydroxyurea in sickle cell anemia: Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia
3. Hydroxyurea therapy in children severely affected with sickle cell disease
4. Hydroxyurea therapy for diverse pediatric populations with sickle cell disease
5. Safety of hydroxyurea in children with sickle cell anemia: Results of the HUG-KIDS study, a phase I/II trial
6. Three-year follow-up of hydroxyurea treatment in severely ill children with sickle cell disease. The French Study Group on Sickle Cell Disease
7. First report of reversal of organ dysfunction in sickle cell anemia by use of hydroxyurea: Splenic regeneration
8. Clinical and laboratory effects of long-term administration of hydroxyurea to patients with sickle cell β-thalassaemia
9. Liver involvement in sickle cell disease
10. Clinical, hematological, and molecular features in Sicilians with Hb S-β-thalassemia
11. Levels of fetal hemoglobin necessary for treatment of sickle cell disease
12. Hematological responses in patients with sickle cell anemia treated with hydroxyurea
13. Sickle hemoglobinopathies in Sicily
14. Antenatal diagnosis of β thalassaemia
15. The great heterogeneity of thalassemia molecular defects in Sicily
16. Hydroxyurea-induced denaturation of normal and sickle cell hemoglobins in vitro
17. Hydroxyurea independent of Hb F alters the erythrocytes of Hb SC disease
18. Cellular effects of hydroxyurea in Hb SC disease
19. Effect of hydroxyurea on Hemoglobin F and water content in the red blood cells of dogs and of patients with sickle cell anemia
20. Hydroxyurea affects cell morphology, cation transport, and red blood cell adhesion in cultured vascular endothelial cells
21. Decrease of very late activation antigen-4 and CD36 on reticulocytes in sickle cell patients treated with hydroxyurea
22. Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The multicenter study of hydroxyurea in sickle cell anemia